The year ahead is shaping up to be one of significant change and uncertainty for the healthcare industry in light of the many global administrative, policy and regulatory developments expected. Nevertheless, there are many solutions, initiatives, and steps organizations can take to position themselves and their patients for healthy outcomes. The start of the Joint Clinical Assessment (JCA) in Europe will require early strategic planning, substantial resource investment and new crossfunctional ways of working. In the United States (US), the possible implications of an administration change will need to be considered alongside various programs aimed at addressing patient access and health outcomes.
In 2025, the focus for all healthcare stakeholders should be to assess how global developments will affect patient access to innovative therapies. As companies navigate a complex and fluctuating healthcare landscape, Cencora’s market access team will continue to keep its finger on the pulse to anticipate and prepare for global trends.